January 10, 2012 — An immune regulator from healthy cord blood stem cells (CB-SCs) can “educate” the T cells of a person with type 1 diabetes (T1D), enabling the pancreas to produce insulin, according to a report published online January 10, 2012, in BMC Medicine.
Yong Zhao, MD, PhD, from the University of Illinois at Chicago, and . . . → Read More: Stem Cell therapy may reverse Type 1 Diabetes
Comments are closed 